Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Possis Medical, Inc. (NasdaqNM:POSS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 31Price hit new 52-week high ($14.92)
Upcoming Events
Sep 19Add this event to your Yahoo! CalendarLive call at 10:30 am ET: Possis Medical, Inc. Q4/FYE Earnings
Location
9055 Evergreen Boulevard, NW
Minneapolis, MN 55433
Phone: (763) 780-4555
Fax: (763) 780-2227
Email: investor@possis.com
Employees (last reported count): 207
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 7%
·Institutional: 15% (17% of float)
(52 institutions)
·Net Inst. Buying: 708.0K shares (+21.53%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Possis Medical, Inc. is a developer, manufacturer and marketer of medical devices. The Company's products include the AngioJet Rheolytic Thrombectomy System, the Perma-Seal Graft, the Perma-Flow Coronary Bypass Graft, and the ePTFE Synthetic Vascular Graft. The Company is currently focused in the further development and marketing of the AngioJet system. The Company markets this system to interventional cardiologists, interventional radiologists, vascular surgeons, and also to physician specialty groups, including vascular, cardiovascular and thoracic surgeons in the United States and in other countries.
More from Market Guide: Expanded Business Description

Financial Summary
Possis Medical, Inc. is a developer, manufacturer and marketer of medical devices, operating in one business segment. For the nine months ended 4/30/01, revenues rose 48% to $20.8 million. Net loss fell 50% to $3.9 million. Revenues reflect the clearances to commence U.S. marketing of the AngioJet System. Lower loss also reflects the cost savings related to the work force reduction and a reduction in sales product demonstrations and samples.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Donald Wegmiller, 62
Chairman
--  --  
Robert Dutcher, 55
Pres, CEO
$251K$86K
Eapen Chacko, 52
CFO, VP-Fin.
--  --  
Irving Colacci, 47
VP, Legal Affairs and HR, Gen. Counsel and Sec.
146K30K
James Gustafson, 44
VP, Quality Systems and Regulatory/Clinical Affairs
140K--  
Dollar amounts are as of 31-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:POSSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$3.625
Recent Price$14.61 
52-Week High
on 31-Aug-2001
$14.92 
Beta1.24 
Daily Volume (3-month avg)141.1K
Daily Volume (10-day avg)95.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+81.2%
52-Week Change
relative to S&P500
+143.1%
Share-Related Items
Market Capitalization$245.2M
Shares Outstanding16.8M
Float15.6M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 4-May-1987
Per-Share Data
Book Value (mrq)$1.01 
Earnings (ttm)-$0.40 
Earnings (mrq)$0.00 
Sales (ttm)$1.62 
Cash (mrq)$0.46 
Valuation Ratios
Price/Book (mrq)14.46 
Price/EarningsN/A 
Price/Sales (ttm)8.99 
Income Statements
Sales (ttm)$27.1M
EBITDA (ttm)-$5.51M
Income available to common (ttm)-$6.68M
Profitability
Profit Margin (ttm)-24.6%
Operating Margin (ttm)-26.9%
Fiscal Year
Fiscal Year EndsJuly 31
Most recent quarter30-Apr-2001
Management Effectiveness
Return on Assets (ttm)-28.97%
Return on Equity (ttm)-34.92%
Financial Strength
Current Ratio (mrq)4.74 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$7.72M
Short Interest
As of 8-Aug-2001
Shares Short1.10M
Percent of Float7.1%
Shares Short
(Prior Month)
1.43M
Short Ratio8.09 
Daily Volume136.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.